The Ledger

Every statement that passed quotation and attribution checks. Mix any filter with any other: certainty 1/5, debate potential 5/5, or both at once.

clear all ✕

why aren't all 13 resolved? a statement only gets an assessment when the public record can support or contradict it. opinions and what-ifs never can, and 1 checkable ones are still open, waiting for their date. predictions held up or didn't; assertions are supported or contradicted. on every card: ▮▮▮▮▮ certainty · ▮▮▮▮▮ debate potential. speakers are clickable

Assertion Open · timeframe Aug 2026
Processed David bars test cleaner for microplastics than agricultural RXBARs
“RX bars were like really bad on, on plasticizers. So microplastics and RX bars predominantly an agricultural product. It's dates, almonds, eggs. David scores like is super clean. It doesn't have any plasticizers, heavy metals, and that's because of its process…”
Peter Rahal Aug 8, 2025 ▶ 34:57 20VC: The $BN Greenoaks Backed Protein Bar | Hitting $100M Revenues in David's First Year: Lessons & Mistakes | $0 to $600M: The Untold RXBAR Story | Product-Market-Fit, Pricing, Branding: What Every Founder Gets Wrong Today with Peter Rahal
Opinion
RXBAR generates $200M in revenue but wasn't an extraordinary acquisition
“I think probably like 200, but profitable right now for, and especially in Mars portfolio, like they need stuff to get to a billion in revenue. And I think that its position is hard to innovate. You can't go down on price because you're using a whole real food…”
Peter Rahal Aug 8, 2025 ▶ 39:40 20VC: The $BN Greenoaks Backed Protein Bar | Hitting $100M Revenues in David's First Year: Lessons & Mistakes | $0 to $600M: The Untold RXBAR Story | Product-Market-Fit, Pricing, Branding: What Every Founder Gets Wrong Today with Peter Rahal
Disclosure
RXBAR was approaching its growth ceiling before selling to Kellogg
“I also like knew we were close to our ceiling.”
Peter Rahal Aug 8, 2025 ▶ 38:00 20VC: The $BN Greenoaks Backed Protein Bar | Hitting $100M Revenues in David's First Year: Lessons & Mistakes | $0 to $600M: The Untold RXBAR Story | Product-Market-Fit, Pricing, Branding: What Every Founder Gets Wrong Today with Peter Rahal
Assertion Not checkable as stated
RXBAR abandoned early fundraising to focus entirely on product creation
“We just totally stopped doing investor work and went straight to just actually designing and making the product.”
Peter Rahal Aug 8, 2025 ▶ 6:17 20VC: The $BN Greenoaks Backed Protein Bar | Hitting $100M Revenues in David's First Year: Lessons & Mistakes | $0 to $600M: The Untold RXBAR Story | Product-Market-Fit, Pricing, Branding: What Every Founder Gets Wrong Today with Peter Rahal
Insight
RXBAR's minimalist packaging design capped product innovation and total market size
“The product portfolio that we could do was defined by quantifiable whole food ingredients. So our design, that famous design of our X-Bar, really was a constraint on where we could innovate. Because you had to formulate stuff that could be communicated on the …”
Peter Rahal Aug 8, 2025 ▶ 38:18 20VC: The $BN Greenoaks Backed Protein Bar | Hitting $100M Revenues in David's First Year: Lessons & Mistakes | $0 to $600M: The Untold RXBAR Story | Product-Market-Fit, Pricing, Branding: What Every Founder Gets Wrong Today with Peter Rahal
Assertion Contradicted
RXBAR reached $161 million in annual revenue at its acquisition
“We did a hundred sixty one million in sales.”
Peter Rahal Aug 8, 2025 ▶ 36:41 20VC: The $BN Greenoaks Backed Protein Bar | Hitting $100M Revenues in David's First Year: Lessons & Mistakes | $0 to $600M: The Untold RXBAR Story | Product-Market-Fit, Pricing, Branding: What Every Founder Gets Wrong Today with Peter Rahal
What-if
Raising early venture capital would have caused RXBAR to make stupid mistakes
“If we would have raised money and had grow like a balance sheet, I think we would have done stupid shit for sure.”
Peter Rahal Aug 8, 2025 ▶ 13:33 20VC: The $BN Greenoaks Backed Protein Bar | Hitting $100M Revenues in David's First Year: Lessons & Mistakes | $0 to $600M: The Untold RXBAR Story | Product-Market-Fit, Pricing, Branding: What Every Founder Gets Wrong Today with Peter Rahal
Disclosure
Early investors offered profitable RXBAR only 1x to 2x revenue valuations
“Whenever we tried, they wanted two times revenue, one times revenue, and we were profitable, you know, from inception more or less.”
Peter Rahal Aug 8, 2025 ▶ 12:38 20VC: The $BN Greenoaks Backed Protein Bar | Hitting $100M Revenues in David's First Year: Lessons & Mistakes | $0 to $600M: The Untold RXBAR Story | Product-Market-Fit, Pricing, Branding: What Every Founder Gets Wrong Today with Peter Rahal
Assertion Partly supported
RXBAR grew revenue by 300% annually for four consecutive years
“Like we were 300% year a year for like five years, four years.”
Peter Rahal Aug 8, 2025 ▶ 36:46 20VC: The $BN Greenoaks Backed Protein Bar | Hitting $100M Revenues in David's First Year: Lessons & Mistakes | $0 to $600M: The Untold RXBAR Story | Product-Market-Fit, Pricing, Branding: What Every Founder Gets Wrong Today with Peter Rahal
Assertion Partly supported
RXBar raised only $10,000 before selling to Kellogg's for $600M
“RX Bar, a snack bar, raised 10,000 dollars to sell for six hundred million dollars to Kellogg's.”
Ryan Caldbeck Nov 2, 2018 ▶ 23:32 20VC: Ryan Caldbeck on Why The Business Model of VC is Broken, Who is To Blame, How The Best Funds Will Use Data Intelligently Moving Forward & Whether We Are In A Consumer Bubble Or Not?
Assertion Not publicly verifiable
RXBAR's early unit economics yielded 50% gross margins
“It cost us a dollar. We sold it for two dollars.”
Peter Rahal Aug 8, 2025 ▶ 9:51 20VC: The $BN Greenoaks Backed Protein Bar | Hitting $100M Revenues in David's First Year: Lessons & Mistakes | $0 to $600M: The Untold RXBAR Story | Product-Market-Fit, Pricing, Branding: What Every Founder Gets Wrong Today with Peter Rahal
Assertion Supported
RXBAR generated $2 million in revenue during its first year
“Two million.”
Peter Rahal Aug 8, 2025 ▶ 10:47 20VC: The $BN Greenoaks Backed Protein Bar | Hitting $100M Revenues in David's First Year: Lessons & Mistakes | $0 to $600M: The Untold RXBAR Story | Product-Market-Fit, Pricing, Branding: What Every Founder Gets Wrong Today with Peter Rahal
Assertion Supported
RXBAR avoided traditional retail distribution for its first two years
“In the beginning, the first 24 months, like, we didn't do any retail. It wasn't in our cost structure, and we also couldn't manufacture enough.”
Peter Rahal Aug 8, 2025 ▶ 10:15 20VC: The $BN Greenoaks Backed Protein Bar | Hitting $100M Revenues in David's First Year: Lessons & Mistakes | $0 to $600M: The Untold RXBAR Story | Product-Market-Fit, Pricing, Branding: What Every Founder Gets Wrong Today with Peter Rahal
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,200 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.